Organoids, artificial intelligence, synthetic data, experimentation in space: how are new technologies revolutionizing the pre-clinical and clinical trials of tomorrow, for the benefit of patients?
The Future Health Forum will be an opportunity to initiate discussions and reflections on the health challenges of tomorrow around the future of clinical trials by bringing together clinicians, researchers, manufacturers and health stakeholders.
Programme :
08:30 a.m. | Welcoming participants
09:00 a.m. | Opening of the day
Agnès PLAGNEUX-BERTRAND, Vice-President in charge of industry and
the productive economy – Toulouse Métropole
Jean-François LEFEBVRE, General Director – Toulouse University Hospital
Professor Jean-Pierre DELORD, General Director – Oncopole Claudius Regaud /IUCT-Oncopole
Eric VACARESSE, President – Eurobiomed competitiveness cluster
09:20 a.m. | The space clinic: 30 years of experience in coordinating and carrying out clinical studies
Dr. Rebecca BILLETTE DE VILLEMEUR, Medical manager of clinical research – MEDES, Institute of Space Medicine and Physiology
09h40 | Innovations scientifiques et essais cliniques Organoïdes & Essais précliniques : plus de prédiction ?
Dr Nathalie VERGNOLLE, INSERM Research Director – Director of the Digestive Health Research Institute
Philippe LLUEL, Managing Director – Urosphere
Pr Emmanuel MAS, Head of Department, Deputy Head of Unit, Department of Gastroenterology, Hepatology, Nutrition and Hereditary Metabolic Diseases – Toulouse University Hospital
Biomarqueurs & Essais cliniques : plus de précision ?
Pierre FONS, Vice President Translational Biomarkers – Evotec
Dr. Carlos GOMEZ ROCA, Early Phase & Clinical Research Unit, Department of Medical Oncology – Oncopole Claudius Regaud
10h40 | Pause café
11:00 a.m. | Artificial data: what uses for therapeutic development? AI and synthetic data: more virtual patients?
Dr Jean-Louis FRAYSSE, Co-founder – BOTdesign, Coordinator of the artificial health data white paper, Member of the new clinical research methodologies group of the AIS F-CRIN
Sylvain FRANCHOISE DAL-MAS, President, Co-founder – Alia Santé
Jimmy AND THE GABELS, Researcher / Clinical Project Manager, Biophysics, Biostatistics and Digital Technologies – PIERRE FABRE Laboratories
Anaïs LLODRA-PEREZ, Innovation projects coordinator – MEDES, Institute of Space Medicine and Physiology
Pr Nicolas SAVY, Institute of Mathematics of Toulouse
12:00 | Conclusion of the morning
Núria PEREZ CULLELL, Medical Director and Patient-Consumer Relations, PIERRE FABRE Laboratories
12:15 p.m. | Lunch break
1:45 p.m. | What are the challenges for patients? Ethics, diversity and consent
Pr Muriel DAHAN, Director of Research and Development – Unicancer
Professor Bettina COUDERC, INSERM – CERPOP Research Director
Dr Emmanuelle RIAL-SEBBAG, INSERM – CERPOP Research Director
15h00 | Conclusion
Eric VACARESSE, President – Eurobiomed competitiveness cluster
